Andrew J. Fromkin Immunovant, Inc. (IMVT) insider trading activity
Andrew J. Fromkin is Director of Immunovant, Inc.. Currently has a direct ownership of 85,852 shares of IMVT, which is worth approximately $2.36 Million. The most recent transaction as insider was on Dec 01, 2025, when has been sold 22,249 shares (Common Stock) at a price of $23.55 per share, resulting in proceeds of $523,963. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
85.9K
20.58%
3M change
14.07%
12M change
Total Value Held
$2.36 Million
Andrew J. Fromkin Transaction History
AJF
Andrew J. Fromkin
Director
New York, NY